August 1st, 2018: Dexorgen attains a grant to identify cellular factors that modulate production of HIV-1 envelope spike. This research will be conducted over a 24 month period from September 15th, 2018 to July 15th, 2020.
Dexorgen attains a grant to identify cellular factors that modulate production of HIV-1 envelope spike